YAVNE, Israel, June 10, 2016, ORBK, /PRNewswire/ — ORBOTECH LTD. (the “Company” or “Orbotech“) (NASDAQ/GSM: ORBK) announced today that its previously announced public offering of 3,850,000 ordinary shares (the “Offering“) was priced at a price to the public of $26.52 per share. The gross proceeds from the Offering before expenses are expected to be approximately$102.1 million. The Company has also granted the underwriter an option to purchase up to 385,000 additional ordinary shares. The Company plans to use the proceeds ofRead more
- Research on Lodonal for HIV related GI complications featured in Plus Magazine
- Cannabis Strategic Ventures and Sunniva Inc. Enter Into Cannabis Extraction Services Agreement
- Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
- Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
- PHI Group Partners with Fintech Green Investment Company
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More